This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mariko Shimonaga: Innovator in Pharmaceutical Chemistry
Introduction
Mariko Shimonaga is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. Her work exemplifies the intersection of innovation and science, showcasing her dedication to advancing medical research.
Latest Patents
Mariko Shimonaga holds a patent for a 3-phenylpropylamine derivative. This invention aims to provide a novel compound with SF-1 antagonist activity and a polyfunctional molecule containing a moiety corresponding to the compound. The patent specifically relates to a 3-phenylpropylamine derivative compound represented by a specific formula, which has implications for the development of SF-1 degraders.
Career Highlights
Mariko is currently associated with Daiichi Sankyo Company, Limited, where she continues to push the boundaries of pharmaceutical innovation. Her work has led to advancements in drug development, particularly in targeting specific biological pathways. With a focus on creating effective therapeutic agents, she has established herself as a key figure in her field.
Collaborations
Mariko collaborates with esteemed colleagues, including Hideaki Kageji and Tomoharu Tsukada. These partnerships enhance her research efforts and contribute to the collective knowledge within the pharmaceutical industry.
Conclusion
Mariko Shimonaga's contributions to pharmaceutical chemistry and her innovative spirit are evident through her patent and collaborations. Her work continues to inspire advancements in medical research and drug development.